Lost or stolen scheduled medicines
Licensees (manufacturers or wholesalers), clinicians and approval holders who are responsible for the manufacture, sale or distribution of scheduled medicines, are required to report discrepancies, losses or theft of these medicines to the Chief Executive, Department of Health.
Clinicians employed by Hospital and Health Services (HHS) are required to report discrepancies, losses or theft of scheduled medicines from HHS facilities to the Chief Executive of the relevant HHS in accordance with local procedures. Contact your local Director of Pharmacy for more information if required.
For locations other than HHSs, report discrepancies, losses or theft of scheduled medicines to the Chief Executive, Department of Health using the forms below:
- Report lost or stolen scheduled medicines (PDF 500 kB) from locations other than Hospital and Health Services. Use this form to notify the Department of discrepancies, lost or stolen scheduled medicines. Email the completed form to MCHTUInvestigations@health.qld.gov.au.
- Details of loss (PDF 376 kB) use this form if you require more space to detail the type of scheduled medicines that have been lost or stolen.
Reporting obligations
The following tables show who has to report discrepancies losses or theft, and they outline the relevant details and reporting requirements (as outlined in the Regulation) for:
- Schedule 8 (controlled drugs)
- Schedule 4 (restricted drugs) and
- Schedule 3 (pseudoephedrine) medicines.
For more information read the Health (Drugs and Poisons) Regulation 1996.
Schedule 8 (controlled drugs)
| Who | Schedule 8 (controlled drugs)—what the regulation states |
|---|---|
| Licensee (manufacturer or wholesaler) | The licensee must immediately give the chief executive written notice about the discrepancy, loss, misappropriation or theft (S50A). |
| Institutions (private hospitals, nursing homes, detention centre, prison) | If the checker knows, or reasonably suspects, a controlled drug has been lost, misappropriated or stolen, immediately give the Chief Executive written notice about the loss, misappropriation or theft (S110). |
| Institutions (public hospitals) | If the checker knows, or reasonably suspects, a controlled drug has been lost, misappropriated or stolen, immediately give the Chief Executive of the Hospital and Health Service written notice about the loss, misappropriation or theft (S110) in accordance with local procedures. |
| Certain nursing practices and Queensland Ambulance Service stations | The person must immediately report to the Chief Executive— (a) a contravention of this regulation; or |
Places other than an institution (dentists, doctors, nurse practitioners, veterinary surgeons, ambulance officers, indigenous health workers, midwives) | The person must immediately give the Chief Executive a written notice about the discrepancy, loss, misappropriation or theft (S116A). |
| Places other than an institution (community pharmacist) | The person should immediately give the Chief Executive a written notice about the discrepancy, loss, misappropriation or theft. |
| Approval holders | As per the condition of your approval for
|
Schedule 4 (restricted drug)
| Who | Schedule 4 (restricted drugs)—what the regulation states |
|---|---|
Licensee (manufacturer or wholesaler) | If a licensee knows, or reasonably suspects that any of the following has been lost, misappropriated or stolen, the licensee must immediately give the Chief Executive a written notice about the loss, misappropriation or theft— (a) a restricted drug that is an anabolic steroidal agent;
(c) S4 pseudoephedrine (S144A). |
Wholesale representative | A wholesale representative must immediately report the loss or theft of a restricted drug to the representative's employer and the nearest police establishment (S151). |
Approval holders | As per the condition of your approval for
|
Schedule 3 (pseudoephedrine)
| Who | Schedule 3 (pseudoephedrine)—what the regulation states |
|---|---|
A person who sells S3 pseudoephedrine (e.g. pharmacist or licensees) | If a person who sells a poison that is S3 pseudoephedrine knows, or reasonably suspects, that any of the poison that is S3 pseudoephedrine has been lost, misappropriated or stolen, the person must immediately give the Chief Executive a written notice about the loss, misappropriation or theft (285B). |
